Analysts Viewpoint RCKT’s latest rating updates from top analysts. Rocket Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Ondrey Aaron unloaded Company’s shares for reported $4257.0 on
Stock Earnings Evercore ISI downgrades Rocket Pharmaceuticals Inc (RCKT) stock to an In-line Rocket Pharmaceuticals Inc’s filing revealed that its Chief Financial Officer Ondrey Aaron unloaded Company’s shares for reported $4257.0 on Jul
Analysts Viewpoint Taking a Closer Look At Rocket Pharmaceuticals Inc (RCKT) Following Its Recent Trade Rocket Pharmaceuticals Inc’s filing revealed that its insider Militello John unloaded Company’s shares for reported $2301.0 on May 20 ’25.